Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini

 
• By Joseph Haas, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Plus deal news involving LianBio/NImmune, REGiMMUNE/Kiji, Chengdu Baiyu/Novartis, Orasis/Optus, Takeda/Wave Life Sciences, Ono/LigaChem, Alchem/Sonnet, Astellas/AviadoBio, Innovent/Ask Pharm and Dr Reddy’s/Gilead.

Asia Deal Watch
• Source: Alamy

More from Deal Watch

More from Scrip